Monday, July 23, 2018
 
 
Company News: Page (1) of 1 - 12/04/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Plasma Fractionation Market Expected To Be Worth US$ 26 Billion By 2022

(December 04, 2017)
By Jack Matt

Florida, December 04, 2017: Blood plasma fractionation insinuates the general strategies of disconnecting the distinctive parts of blood plasma, which in this way is a portion of blood got past blood fractionation. The plasma fractionation industry is an area of the Biopharmaceutical business in which the plasma segment of human blood is handled to extricate helpful items. The business is moderately developed, with the center plasma fractionation innovation unaltered. Factors, for example, developing maturing populace, rising rates of draining and insusceptible issue, and developing utilization of immunoglobulin and alpha-1-antitrypsin are the essential development drivers for the worldwide plasma fractionation market.

The Global Plasma Fractionation Market is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers albumin, immunoglobulin, coagulation factor concentrates, protease inhibitors, other plasma fractionation products. Based on application segmentation it covers neurology, immunology, hematology, haemato-oncology, pulmonology, rheumatology, critical care, others. Based on end user segmentation it covers hospitals and clinics, clinical research laboratories, academic institutes.

The Global Plasma Fractionation Market is expected to exceed more than US$ 25.97 Billion by 2022 at a CAGR of 6.7% in the given forecast period.



You Can Browse Full Report: https://www.marketresearchengine.com/plasma-fractionation-market

The Global Plasma Fractionation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The major driving factors of Global Plasma Fractionation Market are as follows:

  • Increasing use of immunoglobulin in various therapeutic areas
  • Growth in the aging population across the globe
  • Growth in Number of Hemophilic Patients
  • Developing occurrence of respiratory diseases & AATD driving the uptake of alpha-1 antitrypsin
  • Growth in plasma collection

The restraining factors of Global Plasma Fractionation Market are as follows:

  • High cost and limited reimbursements
  • Strict government regulations
  • Pressure of pricing faced by prominent players in the market
  • Emergence of recombinant alternatives

This report provides:

1) An overview of the global market for Global Plasma Fractionation Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Plasma Fractionation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), and Sanquin (Netherlands). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets on Global Plasma Fractionation Market with the reasons given for variations in the growth of the industry in certain regions.

Request Sample Report: https://www.marketresearchengine.com/plasma-fractionation-market

 

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

6.1 Introduction
6.2 Key Industry Trends
6.2.1 Focus on Increasing Fractionation CAPACities and Geographical Expansions
6.2.2 New Indications for Plasma Products
6.2.3 Rising Adoption of SCIG
6.2.4 Increasing Number of Fractionator-Owned Plasma Collection Centers
6.2.5 Growing Plasma Products Market in China
6.2.6 Increasing Focus of Plasma Fractionators Towards Manufacturing and Development of Recombinant Factors
6.3 Porter’s Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry

7 Global Plasma Fractionation Market, By Product

8 Global Plasma Fractionation Market, By Application

9 Global Plasma Fractionation Market, By End User

10 Global Plasma Fractionation Market, By Region

11 Competitive Landscape

12 Company Profiles

12.1 Introduction

12.2 CSL Ltd.

12.3 Grifols S.A.

12.4 Baxalta Incorporated

12.5 Octapharma AG

12.6 Kedrion S.P.A

12.7 China Biologic Products, Inc.

12.8 Biotest AG

12.9 LFB S.A.

12.10 Bio Product Laboratory Ltd. (BPL)

2.11 Sanquin

 

Media Contact

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com

 

 

Source: http://www.financeswire.com/global-plasma-fractionation-market-expected-to-be-worth-us-26-billion-by-2022


Page: 1


Related Keywords:Market,News,Global Plasma Fractionation Market,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines